Standard BioTools Inc.
Standard BioTools Inc. (LAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LAB · as of Jun 8, 2026
Key Statistics
Explore Standard BioTools Inc. Data
lab stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 60.0%
The LAB analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $3.25, representing +304.63% upside from the current price of $0.80.
Competitors & Peers
lab competitorsLAB
ADCT
AVNS
BVS
CBLL
CGEMStock Performance
Full HistoryAbout Standard BioTools Inc.
Standard BioTools Inc. established in 1999 and based in South San Francisco, California, is a key player in providing advanced scientific tools. Formerly known as Fluidigm Corporation until its name …
what is standard biotools inc. · lab stock overview · standard biotools inc. company profile · who is standard biotools inc. ceo · lab NASDAQ · standard biotools inc. headquarters · standard biotools inc. business segments
About Stock Overview & Key Data
Standard BioTools Inc. (LAB) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 10, 2011. As of the latest trading session, LAB stock price is $0.80, with a market capitalization of $313.5M. The stock has returned +6.48% over the past 12 months and -10.16% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Standard BioTools Inc. stock is Buy, with an average 12-month price target of $3.25. In fiscal year 2025, Standard BioTools Inc. reported revenue of $85.3M and net income of -$74.9M. For detailed data — including Standard BioTools Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Standard BioTools Inc. (LAB) stock price is $0.80. The stock is traded on NASDAQ under the ticker symbol LAB. The 52-week range is $0.80 – $1.72.